Search

everythinglearnresearchcommunity

for

Search:↓

Targeting specific T cells may help treat alopecia areata.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

γδ T cells adapt uniquely to different tissues in mice.

Autoimmune reactions may cause both alopecia areata and HAM.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Most HIV-positive patients had skin problems, and conditions like oral thrush and boils were linked to weaker immune systems.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

3D spheroid culture makes stem cells better at reducing inflammation.

Skin cells control immune cell placement, helping the skin respond better to challenges.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Enhancing immune response can improve cancer treatment effectiveness.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.